Table 2.
Overview of first day MBL concentrations and MBL2 genotype.
| Premature | Term | |||
|---|---|---|---|---|
| MBL deficiency groups | n (%) | MBL (µg/ml) Median (range) | n (%) | MBL (µg/ml) Median (range) |
| All subjects | 69 (100·0) | 0·98 (0·01–4·16)* | 16 (100·0) | 1·20 (0·10–3·69) |
| MBL2 genotype | ||||
| YA/YA | 22 | 1·64 (0·12–4·16)* | 6 | 1·75 (0·77–3·69) |
| YA/XA | 13 | 1·37 (0·39–2·84) | 1 | 1·89 |
| XA/XA | 1 | 2·79 | 0 | |
| YA/O | 12 | 0·33 (0·01–0·62) | 2 | 0·61 (0·56–0·65) |
| XA/O | 4 | 0·19 (0·05–1·10) | 1 | 0·10 |
| O/O | 4 | 0·08 (0·02–0·43) | 1 | 0·17 |
| Missing | 13 | 1·15 (0·18–3·63) | 5 | 0·71 (0·20–1·93) |
| MBL expression group | ||||
| High | 35 (50·8) | 1·54 (0·12–4·16)* | 7 (43·8) | 1·80 (0·77–3·69) |
| Medium | 13 (18·8) | 0·33 (0·01–2·79) | 2 (12·5) | 0·61 (0·56–0·65) |
| Low | 8 (11·6) | 0·09 (0·02–1·10) | 2 (12·5) | 0·14 (0·10–0·17) |
| Missing | 13 (18·8) | 1·15 (0·18–3·63) | 5 (31·2) | 0·71 (0·20–1·93) |
| MBL concentrations | ||||
| > 0·7 µg/ml | 40 (58·0)† | 10 (62·5) | ||
| ≤ 0·7 µg/ml | 29 (42·0) | 6 (37·5) | ||
n, number of subjects
*
First day MBL concentration of one neonate missing.
†
The neonate with the missing first day MBL concentration had a concentration of 2·63 µg/ml one week after birth and was therefore considered to have a MBL concentration of > 0·7 µg/ml.